Codeine 30 30 mg (Codeine Phosphate TABLET) 30 MG

Codeine phosphate works by binding to mu-opioid receptors in the brain and spinal cord. This action reduces the perception of pain and suppresses the cough reflex. It is metabolized in the liver, where some of it is converted to morphine, which also contributes to its analgesic effects.

The usual dose of CODEINE 30 is determined by a healthcare professional based on the patient's condition, age, and response to treatment. It is important to follow the prescribed dosage and not to exceed the recommended dose.

CODEINE 30 should be used during pregnancy only if clearly needed and under medical supervision. It is not recommended for use during breastfeeding unless the benefits outweigh the risks, as it can pass into breast milk.

To order CODEINE 30 from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then provide pricing, availability, shipping, and the necessary import paperwork.

CODEINE 30 is an opioid analgesic, which makes it more potent than non-opioid pain relievers like ibuprofen or paracetamol. It is typically used when other pain medications are insufficient. However, it carries a higher risk of side effects and dependence compared to non-opioid alternatives.

CODEINE 30 should be stored below 25°C, in the original pack, and protected from moisture and light. It should be kept out of reach of children and pets to prevent accidental ingestion.

CODEINE 30 is administered orally, typically as a tablet. The tablets should be swallowed whole with a glass of water, and they should not be crushed, chewed, or broken unless directed by a healthcare professional.

The most serious risks associated with CODEINE 30 include respiratory depression, severe allergic reactions, dependence, and addiction. It is important to use this medication under medical supervision and to follow the prescribed dosage to minimize these risks.

CODEINE 30 should not be used by children under 12 years of age, individuals with severe respiratory depression, those with known hypersensitivity to codeine or its components, and those with certain medical conditions such as severe liver or kidney disease unless directed by a healthcare professional.